Cargando…
A Novel Nomogram for Prediction and Evaluation of Lymphatic Metastasis in Patients With Renal Cell Carcinoma
BACKGROUND: Lymphatic metastasis is an important mechanism of renal cell carcinoma (RCC) dissemination and is an indicator of poor prognosis. Therefore, we aimed to identify predictors of lymphatic metastases (LMs) in RCC patients and to develop a new nomogram to assess the risk of LMs. METHODS: Thi...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9035798/ https://www.ncbi.nlm.nih.gov/pubmed/35480102 http://dx.doi.org/10.3389/fonc.2022.851552 |
_version_ | 1784693377659305984 |
---|---|
author | Li, Wenle Wang, Bing Dong, Shengtao Xu, Chan Song, Yang Qiao, Ximin Xu, Xiaofeng Huang, Meijin Yin, Chengliang |
author_facet | Li, Wenle Wang, Bing Dong, Shengtao Xu, Chan Song, Yang Qiao, Ximin Xu, Xiaofeng Huang, Meijin Yin, Chengliang |
author_sort | Li, Wenle |
collection | PubMed |
description | BACKGROUND: Lymphatic metastasis is an important mechanism of renal cell carcinoma (RCC) dissemination and is an indicator of poor prognosis. Therefore, we aimed to identify predictors of lymphatic metastases (LMs) in RCC patients and to develop a new nomogram to assess the risk of LMs. METHODS: This study included patients with RCC from 2010 to 2018 in the Surveillance, Epidemiology, and Final Results (SEER) database into the training cohort and included the RCC patients diagnosed during the same period in the Second Affiliated Hospital of Dalian Medical University into the validation cohort. Univariate and multivariate logistic regression analysis were performed to identify risk factors for LM, constructing a nomogram. The receiver operating characteristic (ROC) curves were generated to assess the nomogram’s performance, and the concordance index (C-index), area under curve value (AUC), and calibration plots were used to evaluate the discrimination and calibration of the nomogram. The nomogram’s clinical performance was evaluated by decision curve analysis (DCA), probability density function (PDF) and clinical utility curve (CUC). Furthermore, Kaplan-Meier curves were performed in the training and the validation cohort to evaluate the survival risk of the patients with lymphatic metastasis or not. Additionally, on the basis of the constructed nomogram, we obtained a convenient and intuitive network calculator. RESULTS: A total of 41837 patients were included for analysis, including 41,018 in the training group and 819 in the validation group. Eleven risk factors were considered as predictor variables in the nomogram. The nomogram displayed excellent discrimination power, with AUC both reached 0.916 in the training group (95% confidence interval (CI) 0.913 to 0.918) and the validation group (95% CI 0.895 to 0.934). The calibration curves presented that the nomogram-based prediction had good consistency with practical application. Moreover, Kaplan-Meier curves analysis showed that RCC patients with LMs had worse survival outcomes compared with patients without LMs. CONCLUSIONS: The nomogram and web calculator (https://liwenle0910.shinyapps.io/DynNomapp/) may be a useful tool to quantify the risk of LMs in patients with RCC, which may provide guidance for clinicians, such as identifying high-risk patients, performing surgery, and establishing personalized treatment as soon as possible. |
format | Online Article Text |
id | pubmed-9035798 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-90357982022-04-26 A Novel Nomogram for Prediction and Evaluation of Lymphatic Metastasis in Patients With Renal Cell Carcinoma Li, Wenle Wang, Bing Dong, Shengtao Xu, Chan Song, Yang Qiao, Ximin Xu, Xiaofeng Huang, Meijin Yin, Chengliang Front Oncol Oncology BACKGROUND: Lymphatic metastasis is an important mechanism of renal cell carcinoma (RCC) dissemination and is an indicator of poor prognosis. Therefore, we aimed to identify predictors of lymphatic metastases (LMs) in RCC patients and to develop a new nomogram to assess the risk of LMs. METHODS: This study included patients with RCC from 2010 to 2018 in the Surveillance, Epidemiology, and Final Results (SEER) database into the training cohort and included the RCC patients diagnosed during the same period in the Second Affiliated Hospital of Dalian Medical University into the validation cohort. Univariate and multivariate logistic regression analysis were performed to identify risk factors for LM, constructing a nomogram. The receiver operating characteristic (ROC) curves were generated to assess the nomogram’s performance, and the concordance index (C-index), area under curve value (AUC), and calibration plots were used to evaluate the discrimination and calibration of the nomogram. The nomogram’s clinical performance was evaluated by decision curve analysis (DCA), probability density function (PDF) and clinical utility curve (CUC). Furthermore, Kaplan-Meier curves were performed in the training and the validation cohort to evaluate the survival risk of the patients with lymphatic metastasis or not. Additionally, on the basis of the constructed nomogram, we obtained a convenient and intuitive network calculator. RESULTS: A total of 41837 patients were included for analysis, including 41,018 in the training group and 819 in the validation group. Eleven risk factors were considered as predictor variables in the nomogram. The nomogram displayed excellent discrimination power, with AUC both reached 0.916 in the training group (95% confidence interval (CI) 0.913 to 0.918) and the validation group (95% CI 0.895 to 0.934). The calibration curves presented that the nomogram-based prediction had good consistency with practical application. Moreover, Kaplan-Meier curves analysis showed that RCC patients with LMs had worse survival outcomes compared with patients without LMs. CONCLUSIONS: The nomogram and web calculator (https://liwenle0910.shinyapps.io/DynNomapp/) may be a useful tool to quantify the risk of LMs in patients with RCC, which may provide guidance for clinicians, such as identifying high-risk patients, performing surgery, and establishing personalized treatment as soon as possible. Frontiers Media S.A. 2022-04-11 /pmc/articles/PMC9035798/ /pubmed/35480102 http://dx.doi.org/10.3389/fonc.2022.851552 Text en Copyright © 2022 Li, Wang, Dong, Xu, Song, Qiao, Xu, Huang and Yin https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Oncology Li, Wenle Wang, Bing Dong, Shengtao Xu, Chan Song, Yang Qiao, Ximin Xu, Xiaofeng Huang, Meijin Yin, Chengliang A Novel Nomogram for Prediction and Evaluation of Lymphatic Metastasis in Patients With Renal Cell Carcinoma |
title | A Novel Nomogram for Prediction and Evaluation of Lymphatic Metastasis in Patients With Renal Cell Carcinoma |
title_full | A Novel Nomogram for Prediction and Evaluation of Lymphatic Metastasis in Patients With Renal Cell Carcinoma |
title_fullStr | A Novel Nomogram for Prediction and Evaluation of Lymphatic Metastasis in Patients With Renal Cell Carcinoma |
title_full_unstemmed | A Novel Nomogram for Prediction and Evaluation of Lymphatic Metastasis in Patients With Renal Cell Carcinoma |
title_short | A Novel Nomogram for Prediction and Evaluation of Lymphatic Metastasis in Patients With Renal Cell Carcinoma |
title_sort | novel nomogram for prediction and evaluation of lymphatic metastasis in patients with renal cell carcinoma |
topic | Oncology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9035798/ https://www.ncbi.nlm.nih.gov/pubmed/35480102 http://dx.doi.org/10.3389/fonc.2022.851552 |
work_keys_str_mv | AT liwenle anovelnomogramforpredictionandevaluationoflymphaticmetastasisinpatientswithrenalcellcarcinoma AT wangbing anovelnomogramforpredictionandevaluationoflymphaticmetastasisinpatientswithrenalcellcarcinoma AT dongshengtao anovelnomogramforpredictionandevaluationoflymphaticmetastasisinpatientswithrenalcellcarcinoma AT xuchan anovelnomogramforpredictionandevaluationoflymphaticmetastasisinpatientswithrenalcellcarcinoma AT songyang anovelnomogramforpredictionandevaluationoflymphaticmetastasisinpatientswithrenalcellcarcinoma AT qiaoximin anovelnomogramforpredictionandevaluationoflymphaticmetastasisinpatientswithrenalcellcarcinoma AT xuxiaofeng anovelnomogramforpredictionandevaluationoflymphaticmetastasisinpatientswithrenalcellcarcinoma AT huangmeijin anovelnomogramforpredictionandevaluationoflymphaticmetastasisinpatientswithrenalcellcarcinoma AT yinchengliang anovelnomogramforpredictionandevaluationoflymphaticmetastasisinpatientswithrenalcellcarcinoma AT liwenle novelnomogramforpredictionandevaluationoflymphaticmetastasisinpatientswithrenalcellcarcinoma AT wangbing novelnomogramforpredictionandevaluationoflymphaticmetastasisinpatientswithrenalcellcarcinoma AT dongshengtao novelnomogramforpredictionandevaluationoflymphaticmetastasisinpatientswithrenalcellcarcinoma AT xuchan novelnomogramforpredictionandevaluationoflymphaticmetastasisinpatientswithrenalcellcarcinoma AT songyang novelnomogramforpredictionandevaluationoflymphaticmetastasisinpatientswithrenalcellcarcinoma AT qiaoximin novelnomogramforpredictionandevaluationoflymphaticmetastasisinpatientswithrenalcellcarcinoma AT xuxiaofeng novelnomogramforpredictionandevaluationoflymphaticmetastasisinpatientswithrenalcellcarcinoma AT huangmeijin novelnomogramforpredictionandevaluationoflymphaticmetastasisinpatientswithrenalcellcarcinoma AT yinchengliang novelnomogramforpredictionandevaluationoflymphaticmetastasisinpatientswithrenalcellcarcinoma |